Skip to main content
Premium Trial:

Request an Annual Quote

Cephalon to Use Eidogen-Sertanty Software for Neurology, Cancer Drug Discovery

NEW YORK, Jan. 5 (GenomeWeb News) - Eidogen-Sertanty today said that Cephalon will use its Kinase Knowledgebase, Target Informatics Platform, and EVE comparative visualization software.


Scientists at the Pennsylvania-based drug maker will use Eidogen-Sertanty's software to support small-molecule drug-discovery projects in their neurology and oncology therapeutic programs, the companies said.


Financial terms of the deal were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.